標題: Titlebook: Endocrine Therapies in Breast and Prostate Cancer; C. Kent Osborne Book 1988 Kluwer Academic Publishers, Boston 1988 carcinoma.cell.clinic [打印本頁] 作者: nourish 時間: 2025-3-21 19:56
書目名稱Endocrine Therapies in Breast and Prostate Cancer影響因子(影響力)
書目名稱Endocrine Therapies in Breast and Prostate Cancer影響因子(影響力)學科排名
書目名稱Endocrine Therapies in Breast and Prostate Cancer網絡公開度
書目名稱Endocrine Therapies in Breast and Prostate Cancer網絡公開度學科排名
書目名稱Endocrine Therapies in Breast and Prostate Cancer被引頻次
書目名稱Endocrine Therapies in Breast and Prostate Cancer被引頻次學科排名
書目名稱Endocrine Therapies in Breast and Prostate Cancer年度引用
書目名稱Endocrine Therapies in Breast and Prostate Cancer年度引用學科排名
書目名稱Endocrine Therapies in Breast and Prostate Cancer讀者反饋
書目名稱Endocrine Therapies in Breast and Prostate Cancer讀者反饋學科排名
作者: RECUR 時間: 2025-3-21 22:27 作者: 幻影 時間: 2025-3-22 03:39 作者: 高談闊論 時間: 2025-3-22 06:41
Pungent Silence: Encounters with Onion,ave consisted of surgical removal of endocrine glands such as ovaries, adrenals, and pituitary or administration of pharmacologic amounts of hormones such as estrogens, androgens, and progestational agents [1]. Although the hormone dependency of human breast cancer has been recognized since the end 作者: Vldl379 時間: 2025-3-22 10:19
Why We Cannot Think about Nonexistents,w cases will be diagnosed in 1988; most will present with metastatic disease. The median survival for patients with newly diagnosed, metastatic prostate cancer is approximately three years. Since the pioneering work of Huggins and Hodges in the 1940s, which demonstrated the androgen-dependence of pr作者: 爭吵 時間: 2025-3-22 13:11 作者: 爭吵 時間: 2025-3-22 17:41
https://doi.org/10.1057/9780230510319d of human breast carcinomas are ‘hormone-dependent’ and respond to various endocrine manipulations, which are usually designed to block the stimulatory effects of estrogen on tumor growth. Although the mechanisms by which additive hormone therapies, such as pharmacologic estrogens or progestins, in作者: Generalize 時間: 2025-3-23 01:16
Representations of Childhood Deathed that in 1987 there were 96,000 newly diagnosed cases and 27,000 deaths from prostatic cancer in the United States [1] Approximately 50% of men with prostatic cancer have advanced disease at the time of initial presentation. The realistic objective of treatment in these patients is palliation rath作者: elastic 時間: 2025-3-23 01:30 作者: 吹牛者 時間: 2025-3-23 05:46
https://doi.org/10.1007/978-1-4613-1731-9carcinoma; cell; clinical trial; hormones; prostate cancer作者: 揮舞 時間: 2025-3-23 12:44
978-1-4612-8974-6Kluwer Academic Publishers, Boston 1988作者: 瑪瑙 時間: 2025-3-23 17:54
Endocrine Therapies in Breast and Prostate Cancer978-1-4613-1731-9Series ISSN 0927-3042 Series E-ISSN 2509-8497 作者: DEBT 時間: 2025-3-23 21:12
Cancer Treatment and Researchhttp://image.papertrans.cn/e/image/309733.jpg作者: 茁壯成長 時間: 2025-3-23 22:45 作者: Intellectual 時間: 2025-3-24 06:10 作者: kindred 時間: 2025-3-24 08:29 作者: 紳士 時間: 2025-3-24 11:17 作者: 吊胃口 時間: 2025-3-24 17:31
Representations of Childhood Deathnts, and estrogen therapy may be associated with fluid retention, thromboembolic complications, gynecomastia, and gastrointestinal side effects. Therefore, an effective systemic therapy readily acceptable to all patients and without side effects remains a desirable goal. Antiandrogens are one of sev作者: nonplus 時間: 2025-3-24 21:04 作者: 注意 時間: 2025-3-25 03:05
Preclinical Studies and Antitumor Mechanism of Action of LHRH Analogues,o suppress ovarian activity, reduce circulating levels of estradiol, and cause a decrease in size of estrogen target tissue [5], including an ability to promote extensive regressions in estrogen receptor-positive, dimethylben-zanthracene-induced mammary tumours [6, 7]. Similarly, in male animals, LH作者: jettison 時間: 2025-3-25 04:24 作者: 發(fā)現 時間: 2025-3-25 10:39
Progestational Agents in the Treatment of Breast Cancer,s, which were the established hormonal agents used in patients with breast cancer at that time. Studies performed in the 1970s and early 1980s have demonstrated the effectiveness of progestins as secondary hormonal therapy for women with breast cancer, with response rates comparable to those of estr作者: notice 時間: 2025-3-25 14:52
0927-3042 tegies for breast and prostate cancer. The first three chapters summarize preclinical and clinical studies of the luteinizing hormone-releasing hormone analogue978-1-4612-8974-6978-1-4613-1731-9Series ISSN 0927-3042 Series E-ISSN 2509-8497 作者: 喃喃訴苦 時間: 2025-3-25 18:42 作者: adequate-intake 時間: 2025-3-25 21:49 作者: 構想 時間: 2025-3-26 00:36 作者: erythema 時間: 2025-3-26 07:46
Aminoglutethimide: Theoretical Considerations and Clinical Results in Advanced Prostate Cancer,with advanced disease respond favorably to such initial therapy [2]. However, most responses to testicular androgen deprivation are incomplete and their duration is relatively short. The average time from initial androgen deprivation to further disease progression is one to two years [3].作者: 楓樹 時間: 2025-3-26 08:32
Effects of Estrogens and Antiestrogens on Cell Proliferation, agonists, and aromatase inhibitors such as amino-glutethimide presumably inhibit growth by reducing the concentration of estrogen available to the cancer cell. The nonsteroidal antiestrogens block the effects of endogenous estrogen at the cancer cell itself by competing with estrogen for its receptor.作者: JIBE 時間: 2025-3-26 14:01
Book 1988ra- pies included surgical endocrine ablative procedures or pharmacologic hor- mone administration, both designed to antagonize the stimulatory effects of sex steroid hormones. In the past decade, several new treatment strategies for these tumors have emerged from basic studies in reproductive biolo作者: allude 時間: 2025-3-26 20:40 作者: 去掉 時間: 2025-3-27 00:07 作者: Prologue 時間: 2025-3-27 04:09
Pungent Silence: Encounters with Onion,h antiestrogens such as tamoxifen [5] or inhibiting estrogen biosynthesis [6]. Following a description of the various pathways required for systemic and local estrogen biosynthesis in postmenopausal women, this chapter will review and update the role of estrogen biosynthesis inhibitors in the treatment of hormone-dependent human breast cancer.作者: 憤世嫉俗者 時間: 2025-3-27 07:32 作者: filicide 時間: 2025-3-27 11:37
Luteinizing Hormone-Releasing Hormone Analogues in the Treatment of Prostate Cancer,state cancers to evaluate treatment morbidity, tumor responsiveness, time to disease progression, and the ultimate parameter of survival. In this chapter, the data generated by the LHRH clinical investigations in the treatment of prostate cancer will be summarized.作者: 敲竹杠 時間: 2025-3-27 13:49 作者: Axillary 時間: 2025-3-27 21:41 作者: 組裝 時間: 2025-3-28 00:56
Antiestrogen Therapy for Breast Cancer, induce ovulation in subfertile women [7, 8]. Interest in the development of antiestrogens as clinically useful agents waned throughout the 1960s. Nevertheless, progress in an understanding of the hormone dependency of breast cancer opened up a new therapeutic application for these drugs.作者: defuse 時間: 2025-3-28 02:52 作者: congenial 時間: 2025-3-28 10:18 作者: demote 時間: 2025-3-28 10:54 作者: GNAT 時間: 2025-3-28 16:29 作者: 品牌 時間: 2025-3-28 21:50
